Bio Basic Inc. is a biotechnology company founded in Toronto, Canada. Since its inception, Bio Basic has developed rapidly by manufacturing various Life Science Products and has served as a one-stop-stop for researchers in the Life Sciences.
Bio Basic strongly committed to innovation and excellence. It strives to do so by directing its efforts into R & D and improving the quality of its products. Bio Basic offers a wide variety of products and services, especially in the field of molecular biology. Several product lines from Bio Basic such as, Molecular Biology Kits, Biochemicals, Synthetic Genes, Peptides and Oligomers have already shown a dominant market presence and have been widely recognized by researchers worldwide.
Bio Basic distinguishes itself from our other competitors by:
1. Being a direct manufacturer of its own product lines, thereby guaranteeing the most competitive prices on the market.
2. Providing a wide range of products and services, to assist with many areas of Life Science Research.
3. Strict quality control – Bio Basic ensures that the quality of its products and services meet the highest in global standards through continuous process improvement and vigorous R&D.
4. Its mission to make high quality research products and services affordable to any lab.
Bio Basic's Product Lines:
Molecular Biology Kits
Electrophoresis Reagents (including DNA, RNA and Protein Markers)
Pre-made Recombinant Protein
Bio Basic's Services:
“To provide the highest quality products and services at the most affordable rates in the industry”.
“To make quality research affordable to any lab, anywhere, thereby allowing scientific breakthroughs to ourish”.
“To deliver an unparalleled quality of service as a team with great care, passion and integrity”.
Takara Bio Europe is a member of the Takara Bio Group, a leading supplier of tools for life scientists worldwide. We serve customers in a wide range of scientific settings, including academic institutions, government research facilities, clinical research, and pharmaceuticals in Europe, Middle East and Africa.
We are a dynamic team of professionals, all dedicated to providing best-in-class solutions to research scientists in advanced biology. Quality, efficiency and the care of our customers, suppliers and staff are paramount to the way we work.
With offices in Paris, France and Göteborg, Sweden, Takara Bio Europe is an outstanding place to work offering the unique opportunity to take an independent position within a European organization.
We are always looking for skilled and motivated professionals.
We strive to deliver innovative technologies that help push every experiment to its fullest potential. Through our brand names TAKARA®, CLONTECH® and CELLARTIS™ we develop innovative technologies in the fields of Cell Biology, Molecular Biology, Proteomics and Stem Cell Research.
Key products include SMART cDNA synthesis kits, including NGS, high-performance qPCR and PCR reagents, Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.
Recently, Takara Bio acquired Rubicon Genomics and WaferGen Bio-systems. As part of the Takara Bio family, they expand our NGS portfolio as well as add R&D, manufacturing, and support for automation systems for NGS and qPCR applications. Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit takarabio.com.
Texas BioGene Inc. (TBG) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of nucleic acid testing kits and services. Founded in Texas, USA (1999), TBG is one of the leading providers of quality HLA Typing Kits for immune matching of bone marrow, cord blood and solid organ transplants. TBG has instituted a comprehensive quality control system and is an ISO13485 accredited manufacturer of medical devices including CE approved typing kits. Currently TBG has R&D, manufacturing and sales operations in the US, Taiwan and China.
Due to it's unparalleled performance in immune matching ability, nucleic acid testing is becoming an essential tool in helping the clinician with critical transplant decisions. TBG is continually pushing to the forefront of nucleic acid testing for diagnostics. From the extraction of nucleic acids, amplification and detection of infectious diseases, genotyping and viral load testing, TBG is commited to expanding the applications of our core technology. To this end TBG's EZbead Systems for automated nucleic acid extraction based on magnetic bead technology have been introduced to help make nucleic acid diagnostics accessible to laboratories worldwide.
Teknova expedites clinical breakthroughs by allowing scientists to focus on discovery, product development, and production. An established leader in custom manufacturing for the life science, biopharma, and healthcare industries, Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.
Priding itself on its agility and customer centricity, Teknova meets the most complex formulation and packaging requirements and delivers with unrivalled speed. The company supports research, clinical, and applied markets with catalog and custom products, delivering cost savings for research, development, and production of diagnostics, vaccines, and therapeutics. All products are manufactured in facilities that are ISO 13485:2016 certified, US FDA 21 CPR Part 820 compliant, and FDA registered.
As a partner to the biopharma sector, Teknova provides end-to-end solutions in the development of reagents and processes for a multitude of established and emerging applications, including vaccine production and gene therapy. The company’s R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire gene therapy workflow.
Teknova was founded in 1996 by Ted Davis, a Genentech scientist, who identified the need for custom media and buffers manufactured to the same quality standards as commercially available, inventoried solutions. The company headquarters and research services facility are located near the San Francisco Bay Area in Hollister, CA, USA, with additional facilities in Mansfield, MA, USA.
Groken Bioscience was found in September 2014 and based in Hong Kong. Our founders and technical board have many years of experience in genomics research and development. The vision of Groken Bioscience is dedicated to improve the healthcare of mankind by utilizing genomics information. We are the first Hong Kong based integrated genomic service provider to introduce the latest genomic research platforms into Hong Kong. Also, we are the first in Asia and China, using big data on microbiome genomics, to provide a tool for individuals to discover their microbiome for health management.
Groken Bioscience has three ambitious missions:
1. Provide Most Advanced Genomics Technologies Service for Researchers
Utilizing state of art next generation sequencing platform such as Illumina HiSeq X, HiSeq2500/2000, NextSeq 500, Miseq and third generation sequencing platform such as PacBio, we are dedicated to facilitate collaborative research and providing the highest quality sequencing service and customized bioinformatics analysis to academics, pharmaceuticals and clinical communities.
2. Develop Cutting Edge Healthcare Management Technologies
We will establish our own R&D laboratory in the Hong Kong Science Park. The laboratory will act as a platform to develop advance technologies and transfer genomic science to quality products or service. We also dedicated to create an ecosystem for high quality genetic services to be delivered from research developers to service providers to health aware consumers through a healthcare management web portal system which can provide business-to-business channels, business-to-consumers healthcare report interface, consumers-to-consumers social networking and Online-to-Offline service delivery.
3. Enhance Research Collaborations
We also serves as a hub for collaborative research. With our team of molecular biologists and bioinformaticians, we aim to collaborate and work with different researchers to advance genomic science.